Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

FromMaster One Thing - Rapamycin Longevity Series


Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

FromMaster One Thing - Rapamycin Longevity Series

ratings:
Length:
71 minutes
Released:
Oct 17, 2023
Format:
Podcast episode

Description

Professor Brian Kennedy from the National University of Singapore is one of the world's leading researchers in the longevity field and has done longevity research for more than two decades. He is active in many different longevity companies and has been the President and CEO at Buck Institute for Research on Aging. Throughout the years he has made many different important and revolutionary longevity discoveries. Currently he is also one of the persons who is trying to move the longevity forward in a much efficient and faster way. This work he is doing in Singapore where he is leading a huge longevity research project. This unique project is something we are going to talk about in the podcast. We will also talk about his research on Rapamycin and other interesting longevity topics.LinksThe centre for Healthy Longevity at the National University of SingaporeHealthy Longevity webinars on YoutubeBrian's research publicationsBrian's TwitterBrian's LinkedInRapamycin resourcesRapamycin.newsRapamycin Facebook groupRapamycin Reddit groupConnect with Krister on:TwitterInstagramDisclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.The world's leading Rapamycin researcher Mikhail Blagosklonny has a long background in cancer research and one important discovery he made around 2000 was that Rapamycin slowed down senescent cancer cells in different ways. After that step by step his interest in the longevity field increased and he developed the very interesting hyperfunction theory of aging. He has made a huge contribution in moving the Rapamycin longevity field forward and his research papers have impacted many people. For example, the Rapamycin physician Alan Green who thanks to these papers took the decision in 2017 to start prescribing Rapamycin off label. Today Alan Green has the biggest clinical experience in the area with more than 1200 patients. A lot of other physicians have after that also taken these steps and one of those are for example physician Peter Attia.LinksMikhail's research publicationsMikhail's twitterHomepageRapamycin resourcesRapamycin.newsRapamycin Facebook groupRapamycin Reddit groupConnect with Krister on:TwitterInstagramDisclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.
Released:
Oct 17, 2023
Format:
Podcast episode